RMTG CEO discusses uplisting path to Nasdaq
Regenerative Medical Technology Group Inc. (RMTG) executives discussed Q1 2026 revenue growth and the strategic process required for a potential Nasdaq listing, while acknowledging current liabilities from business growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day